Alleviation of 5-fluorouracil-induced intestinal mucositis in rats by vitamin E via targeting oxidative stress and inflammatory markers

Journal of Complementary and Integrative Medicine

Volumn 13, Issue 4, 2016, Pages 377-385

  Al Asmari, Abdulrahman Khazim ^a   Khan, Abdul Quaiyoom ^a   Al Asmari, Sarah A ^a   Al Rawi, Abdulqadir ^a   Al Omani, Saud ^a  

^a Prince Sultan Military Medical City   (Saudi Arabia)

Author keywords

5 fluorouracil; inflammation; intestine; mucositis; oxidative stress

Indexed keywords

ALPHA TOCOPHEROL; BIOLOGICAL MARKER; CYCLOOXYGENASE 2; FLUOROURACIL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INDUCIBLE NITRIC OXIDE SYNTHASE; MUCIN; MYELOPEROXIDASE; ANTIINFLAMMATORY AGENT; ANTIOXIDANT; PEROXIDASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CONTROLLED STUDY; ENTERITIS; HISTOPATHOLOGY; INTESTINAL MUCOSITIS; LIPID PEROXIDATION; MALE; MUCOSA INFLAMMATION; NEUTROPHIL CHEMOTAXIS; NONHUMAN; OXIDATIVE STRESS; PROTEIN DEPLETION; PROTEIN EXPRESSION; RAT; VITAMIN SUPPLEMENTATION; ANIMAL; CHEMICALLY INDUCED; DRUG EFFECTS; INFLAMMATION; INTESTINE MUCOSA; METABOLISM; MUCOSITIS; PATHOLOGY; RANDOMIZATION; SMALL INTESTINE; SPRAGUE DAWLEY RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ANTIOXIDANTS; BIOMARKERS; CYCLOOXYGENASE 2; FLUOROURACIL; INFLAMMATION; INTESTINAL MUCOSA; INTESTINE, SMALL; LIPID PEROXIDATION; MALE; MUCINS; MUCOSITIS; NF-KAPPA B; NITRIC OXIDE SYNTHASE TYPE II; OXIDATIVE STRESS; PEROXIDASE; RANDOM ALLOCATION; RATS, SPRAGUE-DAWLEY; VITAMIN E;

EID: 84998579463     PISSN: None     EISSN: 15533840     Source Type: Journal    
DOI: 10.1515/jcim-2016-0043     Document Type: Article

References (49)

1. Peterson DE, Keefe DM, Sonis ST. New frontiers in mucositis. Am Soc Clin Oncol Educ Book 2012:545-51.
2. Harris DJ. Cancer treatment-induced mucositis pain: strategies for assessment and management. Ther Clin Risk Manage 2006;2:251.
3. Rubenstein EB, Peterson DE, Schubert M, Keefe D, McGuire D, Epstein J, et al. Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 2004; 100 (S9):2026-46.
4. Elting LS, Cooksley C, Chambers M, Cantor SB, Manzullo E, Rubenstein EB. The burdens of cancer therapy. Cancer 2003;98:1531-9.
5. Longley DB, Harkin DP, Johnston PG. 5-fluorouracil: mechanisms of action and clinical strategies. Nat Rev Cancer 2003;3:330-8.
6. Lalla RV, Peterson DE. Treatment of mucositis, including new medications. Cancer J 2006;12:348-54.
7. 3 receptor antagonists ameliorate 5-fluorouracil-induced intestinal mucositis by suppression of apoptosis in murine intestinal crypt cells. Br J Pharmacol 2013;168:1388-400.
8. Sonis ST, Elting LS, Keefe D, Peterson DE, Schubert M, Hauer-Jensen M, et al. Perspectives on cancer therapy-induced mucosal injury. Cancer 2004;100(S9):1995-2025.
9. Kwon Y. Mechanism-based management for mucositis: option for treating side effects without compromising the efficacy of cancer therapy. Onco Targets Ther 2016:9;2007-16.
10. Conklin KA. Chemotherapy-associated oxidative stress: impact on chemotherapeutic effectiveness. Integr Cancer Ther 2004;3:294-300.
11. Yoshino F, Yoshida A, Nakajima A, Wada-Takahashi S, Takahashi S-S, Lee MC-I. Alteration of the redox state with reactive oxygen species for 5-fluorouracil-induced oral mucositis in hamsters. PloS One 2013;8:e82834.
12. Chang C-T, Ho T-Y, Lin H, Liang J-A, Huang H-C, Li C-C, et al. 5-Fluorouracil induced intestinal mucositis via nuclear factor-κB activation by transcriptomic analysis and in vivo bioluminescence imaging. PLoS One 2012;7:e31808.
13. Lalla RV, Sonis ST, Peterson DE. Management of oral mucositis in patients who have cancer. Dent Clin North Am 200852:61-77.
14. Nazrun A, Norazlina M, Norliza M, Nirwana S. The anti-inflammatory role of vitamin E in prevention of osteoporosis. Adv Pharmacol Sci 2011;2012:142702.
15. Singh U, Devaraj S. Vitamin E: inflammation and atherosclerosis. Vitamins Hormones 2007;76:519-49.
16. Yang CS, Lu G, Ju J, Li GX. Inhibition of inflammation and carcinogenesis in the lung and colon by tocopherols. Ann New York Acad Sci 2010;1203:29-34.
17. Bhartiya US, Raut YS, Joseph LJ, Hawaldar RW, Rao BS. Evaluation of the radioprotective effect of turmeric extract and vitamin E in mice exposed to therapeutic dose of radioiodine. Indian J Clin Biochem 2008;23:382-6.
18. Amin KA, Hashem KS, Al-muzafar HM, Taha EM. Oxidative hepatotoxicity effects of monocrotaline and its amelioration by lipoic acid, S-adenosyl methionine and vitamin E. J Complement Integr Med 2014;11:35-41.
19. Al-Asmari AK, Khan AQ, Al-Qasim AM, Al-Yousef Y. Ascorbic acid attenuates antineoplastic drug 5-fluorouracil induced gastrointestinal toxicity in rats by modulating the expression of inflammatory mediators. Toxicology Reports 2015;2:908-16.
20. Bradley PP, Priebat DA, Christensen RD, Rothstein G. Measurement of cutaneous inflammation: estimation of neutrophil content with an enzyme marker. J Invest Dermatol 1982;78:206-9.
21. Utley HG, Bernheim F, Hochstein P. Effect of sulfhydryl reagents on peroxidation in microsomes. Arch Biochem Biophys 1967;118:29-32.
22. Shiota A, Hada T, Baba T, Sato M, Yamanaka-Okumura H, Yamamoto H, et al. Protective effects of glycoglycerolipids extracted from spinach on 5-fluorouracil induced intestinal mucosal injury. J Med Invest 2010;57:314-20.
23. Sonis ST. The pathobiology of mucositis. Nat Rev Cancer 2004;4:277-84.
24. Wu JT, Kral JG, The NF-. κB/IκB signaling system: a molecular target in breast cancer therapy. J Surg Res 2005;123:158-69.
25. Yeoh AS, Gibson RJ, Yeoh EE, Bowen JM, Stringer AM, Giam KA, et al. A novel animal model to investigate fractionated radiotherapy-induced alimentary mucositis: the role of apoptosis, p53, nuclear factor-κB, COX-1, and COX-2. Mol Cancer Ther 2007;6:2319-27.
26. Sonis ST. The biologic role for nuclear factor-kappaB in disease and its potential involvement in mucosal injury associated with anti-neoplastic therapy. Crit Rev Oral Biol Med 2002;13:380-9.
27. Calfee-Mason KG, Spear BT, Glauert HP. Effects of vitamin E on the NF-κB pathway in rats treated with the peroxisome proliferator, ciprofibrate. Toxicol Appl Pharmacol 2004;199:1-9.
28. Cindrova-Davies T, Spasic-Boskovic O, Jauniaux E, Charnock-Jones DS, Burton GJ. Nuclear factor-kappa B, p38, and stressactivated protein kinase mitogen-activated protein kinase signaling pathways regulate proinflammatory cytokines and apoptosis in human placental explants in response to oxidative stress: effects of antioxidant vitamins. Am J Pathol 2007;170:1511-20.
29. Ekstrand-Hammarstrom B, Osterlund C, Lilliehook B, Vitamin BA. E down-modulates mitogen-activated protein kinases, nuclear factor-kappaB and inflammatory responses in lung epithelial cells. Clin Exp Immunol 2007;147:359-69.
30. Pal A, Alam S, Singhal J, Kumar R, Ansari KM, Protective DM. Effect of topical application of α-tocopherol and/or N-acetyl cysteine on argemone oil/alkaloid-induced skin tumorigenesis in mice. Nutr Cancer 2013;65:78-87.
31. Sonis S, O'Donnell K, Popat R, Bragdon C, Phelan S, Cocks D, et al. The relationship between mucosal cyclooxygenase-2 (COX-2) expression and experimental radiation-induced mucositis. Oral Oncol 2004;40:170-6.
32. Freitas APF, Bitencourt FS, Brito GAC, de Alencar NMN, Ribeiro RA, Lima-Júnior RCP, et al. Protein fraction of Calotropis procera latex protects against 5-fluorouracil-induced oral mucositis associated with downregulation of pivotal pro-inflammatory mediators. Naunyn-Schmiedeberg's Arch Pharmacol 2012;385:981-90.
33. Lalla RV, Pilbeam CC, Walsh SJ, Sonis ST, Keefe DM, Peterson DE. Role of the cyclooxygenase pathway in chemotherapyinduced oral mucositis: a pilot study. Support Care Cancer 2010;18:95-103.
34. Dubois RN, Abramson SB, Crofford L, Gupta RA, Simon LS, Van De Putte LB, et al. Cyclooxygenase in biology and disease. FASEB J 1998;12:1063-73.
35. Egger T, Schuligoi R, Wintersperger A, Amann R, Malle E, Sattler W. Vitamin E (alpha-tocopherol) attenuates cyclo-oxygenase 2 transcription and synthesis in immortalized murine BV-2 microglia. Biochem J 2003;370:459-67.
36. Huang T-Y, Chu H-C, Lin Y-L, Ho W-H, Hou H-S, Chao Y-C, et al. Minocycline attenuates 5-fluorouracil-induced small intestinal mucositis in mouse model. Biochem Biophys Res Commun 2009;389:634-9.
37. Leitão RF, Ribeiro RA, Bellaguarda EA, Macedo FD, Silva LR, Oriá RB, et al. Role of nitric oxide on pathogenesis of 5-fluorouracil induced experimental oral mucositis in hamster. Cancer Chemother Pharmacol 2007;59:603-12.
38. Leitão RF, Brito GA, Oriá RB, Braga-Neto MB, Bellaguarda EA, Silva JV, et al. Role of inducible nitric oxide synthase pathway on methotrexate-induced intestinal mucositis in rodents. BMC Gastroenterol 2011;11:90.
39. Lima-Júnior RC, Figueiredo AA, Freitas HC, Melo ML, Wong DV, Leite CA, et al. Involvement of nitric oxide on the pathogenesis of irinotecan-induced intestinal mucositis: role of cytokines on inducible nitric oxide synthase activation. Cancer Chem Pharmacol 2012;69:931-42.
40. Ohta Y, Imai Y, Kaida S, Kamiya Y, Kawanishi M, Hirata I. Vitamin E protects against stress-induced gastric mucosal lesions in rats more effectively than vitamin C. Biofactors 2010;36:60-9.
41. Khanduja KL, Avti PK, Kumar VP, Chander Mohan Pathak S. Inhibitory effect of vitamin E on proinflammatory cytokines-and endotoxin-induced nitric oxide release in alveolar macrophages. Life Sci 2005;76:2669-80.
42. Calvisi DF, Ladu S, Hironaka K, Factor VM, Thorgeirsson SS. Vitamin E down-modulates iNOS and NADPH oxidase in c-Myc/TGF-alpha transgenic mouse model of liver cancer. J Hepatol 2004;41:815-22.
43. Heinecke JW. Pathways for oxidation of low density lipoprotein by myeloperoxidase: tyrosyl radical, reactive aldehydes, hypochlorous acid and molecular chlorine. Biofactors 1997;6:145-55.
44. Klebanoff SJ. Myeloperoxidase: friend and foe. J Leukocyte Biol 2005;77:598-625.
45. Davies MJ, Hawkins CL, Pattison DI, Rees MD. Mammalian heme peroxidases: from molecular mechanisms to health implications. Antioxid Redox Signaling 2008;10:1199-234.
46. Mashtoub S, Tran CD, Howarth GS. Emu oil expedites small intestinal repair following 5-fluorouracil-induced mucositis in rats. Exp Biol Med 2013;238:1305-17.
47. Rahman S, Bhatia K, Khan AQ, Kaur M, Ahmad F, Rashid H, et al. Topically applied vitamin E prevents massive cutaneous inflammatory and oxidative stress responses induced by double application of 12-O-tetradecanoylphorbol-13-acetate (TPA) in mice. Chem Biol Interact 2008;172:195-205.
48. Sapmaz-Metin M, Topcu-Tarladacalisir Y, Uz YH, Inan M, Omurlu IK, Cerkezkayabekir A, et al. Vitamin E modulates apoptosis and c-jun N-terminal kinase activation in ovarian torsion-detorsion injury. Exp Mol Pathol 2013;95:213-19.
49. Thorpe D, Stringer A, Butler R. Chemotherapy-induced mucositis: The role of mucin secretion and regulation, and the enteric nervous system. Neurotoxicology 2013;38:101-5.